Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
05:54am, Thursday, 15'th Jun 2023
Alphabet could shake things up with its AI and quantum computing efforts. Brookfield Renewable is helping change where our energy comes from.
2 Magnificent Growth Stocks to Buy Before the Next Bull Market
05:12am, Thursday, 15'th Jun 2023
Investors are contending with a different environment than a few years ago, but that doesn't mean the best market days are in the past. Pinterest is growing where it counts, and user monetization is o
Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)
10:30pm, Tuesday, 13'th Jun 2023
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Goldman Sachs 44th Annual Global Healthcare Conference Call June 13, 2023 5:40 PM ET Company Participants Reshma Kewalramani - President and Chief Ex
3 No-Brainer Stocks to Buy in June
06:14am, Saturday, 10'th Jun 2023
Axsome Therapeutics is a rising star in biotech. Pfizer is too cheap to pass up.
FDA Accepts Vertex (VRTX), CRISPR's BLA Filings for Exa-Cel
02:43pm, Friday, 09'th Jun 2023
The FDA grants priority review to Vertex (VRTX)/CRISPR's (CRSP) filings for exa-cel in SCD, with a final decision expected in December.
2 Top Biotech Stocks to Buy in June
10:15am, Friday, 09'th Jun 2023
The biotech sector remains a fertile place of innovation that can enrich an investor. Gilead has a potential oncology blockbuster, and the stock offers a sizable dividend.
5 Top Stocks to Buy in June
09:21am, Thursday, 08'th Jun 2023
Investors should get in the habit of buying stocks on a regular basis. A diversified portfolio helps minimize the risk that comes with concentrating capital in too few companies or industries.
Vertex (VRTX) Stock Poised Well for Growth in 2023: Here's Why
10:03am, Wednesday, 07'th Jun 2023
Vertex Pharmaceuticals (VRTX) stock is likely to be driven by several catalysts this year. Multiple clinical milestones are likely to be achieved in 2023 and 2024, both in its CF and non-CF portfolio.
A New S&P 500 Bull Market Is Nearly Here: 3 No-Brainer Stocks to Buy Sooner Rather Than Later
05:52am, Wednesday, 07'th Jun 2023
Amazon is already in a bull market of its own and has plenty of room to run. Berkshire Hathaway offers broad exposure to more sectors than any other stock.
Wall Street Says This Growth Stock Is a Buy, but Is It Overvalued?
09:30am, Saturday, 03'rd Jun 2023
Vertex Pharmaceuticals' shares look pricey at first glance. But its revenue in the next half-decade should grow at a good pace.
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
07:45am, Saturday, 03'rd Jun 2023
Vertex Pharmaceuticals' main franchise has no competition, and it boasts several promising programs. DexCom's opportunities in the continuous glucose monitoring market make it an attractive long-term
Why Is Vertex (VRTX) Down 6% Since Last Earnings Report?
12:47pm, Wednesday, 31'st May 2023
Vertex (VRTX) reported earnings 30 days ago. What's next for the stock?
Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire Richer
10:05am, Wednesday, 31'st May 2023
The healthcare and lending markets represent multitrillion-dollar opportunities. Vertex Pharmaceuticals has a competitive edge and its foot in the door of multiple underserved markets.
Vertex to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference on June 13
08:01am, Tuesday, 30'th May 2023
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in the Goldman Sachs 44th Annual Global Healthcare Conference. Dr. Reshma Kewalrama
Wall Street Thinks This Stock Will Only Rise 12%: Here's Why It Could Jump a Lot More
05:53am, Sunday, 28'th May 2023
Some analysts see Vertex's sales growth slowing with no immediate major impact from the anticipated approval of exa-cel. However, forward-looking investors could be excited by other big news from Vert
